Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Amphion Innovations Plc LSE:AMP London Ordinary Share GB00B0DJNP99 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 0.15 0.00 01:00:00
Bid Price Offer Price High Price Low Price Open Price
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Financial 0.11 -13.64 -7.29
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 0.15 GBX

Amphion Innovations (AMP) Latest News

Real-Time news about Amphion Innovations Plc (London Stock Exchange): 0 recent articles
More Amphion Innovations News
Amphion Innovations Investors    Amphion Innovations Takeover Rumours

Amphion Innovations (AMP) Discussions and Chat

Amphion Innovations (AMP) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Amphion Innovations trades in real-time

Amphion Innovations (AMP) Top Chat Posts

DateSubject
28/7/2021
09:20
Amphion Innovations Daily Update: Amphion Innovations Plc is listed in the General Financial sector of the London Stock Exchange with ticker AMP. The last closing price for Amphion Innovations was 0.15p.
Amphion Innovations Plc has a 4 week average price of 0p and a 12 week average price of 0p.
The 1 year high share price is 0p while the 1 year low share price is currently 0p.
There are currently 209,175,888 shares in issue and the average daily traded volume is 0 shares. The market capitalisation of Amphion Innovations Plc is £313,763.83.
13/12/2020
10:13
calton1: Many thanks to 2Pablo for this extraordinary news. At the very least the shareholders might expect to see some accounts after all this time but more importantly an update on specifically what assets this company holds. It is really most unusual for a company with as many (unhappy) shareholders as AMP to remain dormant for a whole year without any communications and as we now learn without any plan whatsoever. This speaks volumes about the board and sadly may explain why we have all lost out by backing them. I would like to know what everyone else thinks because it seems we should consider what options are open.
16/2/2019
08:38
gclark: I am out of these now! With the fall in the price of MTFB, AMP is in high negative equity. I was investing in AMP for the price rise in MTFB, and the gearing on MTFB price rises, which obviously didn't happen. The loan note holders had their debt guaranteed by MTFB shares, which were at 30p+ at the time, and AMP are committed to finding any additional moneys to pay off that debt if the MTFB shares don't cover it, which they don't do now. I can't see where that money could come from, and it has these enormous debts to past and present directors, so I think this company will struggle to survive quite quickly.
15/2/2019
09:41
dave4545: I do not think anybody cares anymore about facts. Aim is always a ponzi so people think can I buy and sell for a quick profit and that to many is yes today. I think AMP need at least 90p to get into a positive balance sheet and people are piling into Amp because Mtfb has trebled from the low of 5 to 15p. Mtfb has to rise another 500% just for AMP to clear their debt/liabilities. 2 weeks ago Mtfb 44p v Amp 0.52p offer Now Mtfb 15p and people are paying 0.55p
14/2/2019
08:15
dave4545: Not sure why people are buying Amp again Mtfb at 6p means Amp's valuation has all been wiped out.
14/2/2019
07:47
dave4545: Just did not make sense as a simple maths equation ! When Mtbf was 44p Amp was 0.525p offer which was good value. It then went nuts being chased up as actually a chance as Mtfb kept climbing Amp's value could wipe out their liabilities. But when Mtfb started drifting Amp should have done the same but for some reason the penny punters decided it was still worth the risk paying the highs on good news for Mtfb. I did say take profits here.
22/8/2018
07:45
2pablo: That 'book value' was confusing me, still is, and is an accounting term which I think represents the total value AMP shares would be worth should Motif be liquidated. In fact our shares are worth considerably more in the market. We retain 8.51% with 24,475,591 shares. These if sold @33.5p as today's were would bring in £8.2m or $10.6m. So we are well able to cover the loan Facility outstanding if we have to keep selling. As discussed previously, don't think this is the end of Amp's debts, far from it. Someone on MTFB LSE BB stated he thought AMP's selling and 'overhang' were having considerable drag on the MTFB share price Maybe that is so, in which case we are doing ourselves out of deserved money payback from a company with considerable prospects. Not sure of this effect myself because we state we are selling directly to an Institutional Investor each time, who can't be dumping them as they'd often be at a loss.
14/8/2018
12:43
sorksandnorks: Good to see some views on AMP being aired. From the AMP website, it appears that AMP has holdings in the following companies. They are listed showing the % held by AMP and my estimate of their values - I have been very strict with these and some of those marked "nil value" may very well be worth something but I am considering the worst case scenario. Access - 15.07% - nil value Firestar - 11.86% - nil value Polarean - 24.0% - today's market cap = £11.7m, hence AMP's share = £2.8m MotifBio - 9.5% - today's market cap = £102.3m, hence AMP's share = £9.7m Private Markets - 25.33% - nil value Wellgen - 24.34% - nil value Datatern - 100% - nil value From this, AMP's market cap today should be £2.8m + £9.7m = £12.5m. But, on ADVFN this morning, AMP's market cap = £1.7m and AMP's mid share price = 0.8p. So, ignoring any debt, AMP's mid share price should be (12.5/1.7) x 0.8 = 5.88p. The problem, of course, is the debt and I do not know how much that is. If anyone does can they please post it on this board so that I can work out what I think the mid share price should be. Many thanks.
12/8/2018
12:51
hoggar: Amp will respond as if on steroids! Not too sure about that statement. This company is so heavily in debt its total assets will not cover due payment in time. As I have posted many times over the years on this post, Morgan needs to incorporate a new business strategy. It would appear he has finally realised this fact and gone away to draw up a new business model for Amphion and save his considerable investment. Time is his enemy at the moment and the stagnant performance of current investments will not pay the monthly instalments or indeed the end of year repayments. Another restructuring is in the offering if the loan bearers want their money on time. The trouble is, Morgan’s curriculum vitae is quite frankly pathetic. His new business plan involves assisting late stage IPO businesses with advising and collecting financial investment support. Now where have we heard that before!!! That might be a nice little earner for him with the exorbitant fees he and his team will no doubt demand, but what does the investor get, debt and more debt suppressing the stock. In the fifteen years since Amphion listed he has managed the company down to junk status. Spending tens of millions of investor’s money on American patent lawyers chasing the likes of Microsoft and SAF for infringements was like the David and Goliath fairy tale. The current situation is quite dismal indeed. With only a 9.5% holding in Motif it is almost certain the next to go will be its holding in Polarean to fend off the sharks. Even if Motif suddenly gained full approval the current mounting debt will dilute and hold back the share price A better scenario would be a large Bio company buy out. This might be what Morgan and Amphion are hoping for in the coming months.
04/10/2017
09:58
bullet ant: Motif Bio PLC Holding(s) in Company 25/09/2017 7:01am UK Regulatory (RNS & others) Amphion (LSE:AMP) Historical Stock Chart 1 Month : From Sep 2017 to Oct 2017 Click Here for more Amphion Charts. TIDMMTFB TIDMAMP RNS Number : 6347R Motif Bio PLC 25 September 2017 25 September 2017 Motif Bio plc ("Motif" or the "Group") Holding(s) in the Company Motif Bio plc (AIM: MTFB), the clinical stage biopharmaceutical company specialising in developing novel antibiotics, announces that it was informed on 22 September 2017 by Amphion Innovations plc ("Amphion") that a total of 4,390,000 ordinary shares in the Company had been sold in respect of a partial repayment of a loan facility, which is secured by Motif Bio shares held by Amphion. Amphion is now the beneficial owner of 37,150,645 ordinary shares in the Company, representing 14.1% of the issued share capital. Following this sale, Amphion has agreed an amendment to the loan facility with its lender such that no further Motif Bio shares will be sold before 15 January 2018. The full details of this amendment may be found in the RNS announcement released by Amphion today. The TR-1 disclosure is set out below.
13/6/2015
23:51
topinfo: Well AMP is massively undervalued right now on MTFB stake and now its other listed company KROMEK has just been tipped in The Mail on Sunday MIDAS Main Share Tip, meaning a big increase in KMK share price on Monday which in turn should lift AMP share price up alot too. The story is just getting better and better at AMP and we aint seen nothing yet as it still has another several companies it owns large stakes in so we could and should see one or more IPO`s soon and a huge re-rating of AMP is going to take place from here. http://www.dailymail.co.uk/money/investing/article-3123022/MIDAS-SHARE-TIPS-Kromek-s-scanners-stop-make-bomb.html
Amphion Innovations share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
AMP
Amphion In..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210729 05:00:42